Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,416,058
-$180,215 QoQ
Shares Held
2,271
+9.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#585
of 1,322 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Columbia Bank holds $1,428,858 across 2 Biotechnology names. REGN ranks #1 (99.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,271 | $1,416,058 | |
| 2 | GERN |
Geron Corp
|
10,000 | $12,800 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,416,058 | 2,271 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,596,273 | 2,066 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $1,511,321 | 1,958 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,247,676 | 2,219 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $1,126,125 | 2,145 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,161,274 | 1,831 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,092,713 | 1,534 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,499,068 | 1,426 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $1,465,135 | 1,394 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $1,262,786 | 1,312 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||